Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now shows No longer looking for participants, indicating recruitment has closed. New or updated help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a standardized Intervention/Treatment label and a new revision note (Revision: v3.6.0).SummaryDifference0.5%

- Check20 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a newer version of the page/document.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page was published. This update does not alter the study content or layout beyond the version reference.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record now marks the trial as Completed, replacing the prior Active, not recruiting status. The update includes date stamps and a revision tag (v3.5.3), indicating documentation updates associated with completion.SummaryDifference0.6%

- Check70 days agoChange DetectedRevision note added: Revision: v3.5.2; Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check98 days agoChange DetectedUpdated the page versioning: added revision v3.5.0 and removed revision v3.4.3. This updates metadata rather than core study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.